Clinical Trials on Product Safety in Korea, Republic of
Total 22 results
-
SPARK BiopharmaCompletedPharmacokinetics | Pharmacodynamics | Safety Issues | TolerabilityKorea, Republic of
-
Inje UniversityCompletedBowel Preparation, Efficacy, Tolerability, SafetyKorea, Republic of
-
Seoul National University HospitalCompletedPatient Safety During Central Venous CatheterizationKorea, Republic of
-
Korea Otsuka Pharmaceutical Co., Ltd.Recruiting
-
Keimyung University Dongsan Medical CenterCompletedPatient Safety During Central Venous CatheterizationKorea, Republic of
-
Yonsei UniversityRecruiting
-
LG ChemCompletedBioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy VolunteersKorea, Republic of
-
PfizerCompletedProduct Surveillance, PostmarketingKorea, Republic of
-
Catholic Kwandong UniversityKorea University Guro HospitalCompletedImmune Response | SafetyKorea, Republic of
-
Asan Medical CenterDankook UniversityUnknownFeasibility | Efficacy | SafetyKorea, Republic of
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2 | Adverse Effects | Safety | VaccinesKorea, Republic of
-
Bundang CHA HospitalKorea Evaluation Institute of Industrial TechnologyUnknownStroke | Safety | Treatment Outcome | Erythropoietin | Umbilical Cord BloodKorea, Republic of
-
Hyundai PharmCompletedEvaluate the Efficacy and Safety of Levotuss CR Tab. in Comparison With Levotuss Syrup in Patients With Cough Due to Acute or Chronic BronchitisKorea, Republic of
-
Children's National Research InstituteCompleted
-
Stemirna TherapeuticsRecruitingEfficacy | Safety | ImmunogenicityLao People's Democratic Republic
-
Stemirna TherapeuticsActive, not recruitingEfficacy | Safety | ImmunogenicityLao People's Democratic Republic
-
George Washington UniversityWithdrawnQuality of Life | Satisfaction | Safety IssuesUnited States
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, Spain, France, Italy, Korea, Republic of, Poland
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDsFrance, Germany, Hungary, Canada, Australia, Austria, Czech Republic, Switzerland
-
Population Health Research InstituteCharles University, Czech Republic; Centre hospitalier de l'Université de Montréal... and other collaboratorsCompletedthe Efficacy and Safety of Off-pump CABGCanada, China, Colombia, India, Chile, Argentina, Brazil, Czech Republic, France, Italy, Poland, Turkey, United Kingdom
-
Biotronik, Inc.CompletedSafety of the ProMRI Pacemaker System Under Specific MRI ConditionsUnited States
-
Georgetown UniversityActive, not recruitingPain | Safety Issues | Pancreas FibrosisUnited States